Skip to main content
. Author manuscript; available in PMC: 2014 May 22.
Published in final edited form as: J Matern Fetal Neonatal Med. 2011 Jan 10;24(8):1002–1012. doi: 10.3109/14767058.2010.538454

Table I.

Study population characteristics

Gene (mRNA) expression study
MicroRNA expression study
Characteristics High Vitamin D
(≥31.7 ng/ml)*
Low Vitamin D
(<25.5 ng/ml)
High Vitamin D
(≥31.7 ng/ml)
Low Vitamin D
(<25.5 ng/ml)
Number (N) 11 10 6 7
Age, years** 34.18 (3.9) 33.2 (5.5) 34.33 (3.1) 33.43 (2.4)
Gestational Age, weeks** 15.91 (2.2) 16.3 (2.5) 15.14 (1.9) 16.84 (2.1)
Pre-pregnancy BMI (kg/m2)** 21.58 (3.1) 23.39 (2.8) 22.87 (3.7) 26.40 (5.6)
  Overweight (≥24kg/m2) 1 (10%) 3 (30%) 2 (29%) 1 (14%)
Non-Hispanic Whites 11 (100%) 10 (100%) 6 (100%) 7 (100%)
Married 11 (100%) 9 (90%) 6 (100%) 7 (100%)
Nulliparous 5 (45%) 4 (40%) 4 (66.7%) 3 (42.9%)
Gravidity** 2.64 (1.62) 2.10 (1.60) 2.17 (2.4) 2.00 (0.6)
Season of blood draw
  Spring/Summer 5 (46.5) 5 (50%) 2 (33.3%) 3 (42.9%)
  Fall/Winter 6 (64.5) 5 (50%) 4 (66.7%) 4 (57.1%)
Plasma 25-hydroxyvitamin D (25-[OH] D) concentrations, ng/ml** 38.84 (7.0) 22.09 (2.6) 39.22 (6.1) 22.84 (2.0)
*

mean (standard deviation), otherwise number (%)

**

Assessed by measuring maternal early pregnancy plasma 25-hydroxyvitamin D (25-[OH] D) concentrations

Abbreviations: GA=gestational age at blood draw, BMI=body mass index

***

The only statistically significant difference (p-value < 0.05) between the two groups in each experiment is the difference between vitamin D levels.